Drooid Logo
Back to story perspectives

Full Breakdown

FDA Issues Highest-Risk Class I Recall for Made Fresh Salads Products

By Drooid · · How we work

Core Event

The Food and Drug Administration (FDA) has assigned a Class I risk rating—the agency’s highest level of danger—to a voluntary recall announced by New York-based Made Fresh Salads. The recall, issued in September, covers all ready-to-eat deli-style salads, assorted cream-cheese products, and half-size aluminum pans that may be contaminated with *Listeria monocytogenes*. In total, 61 distinct products are affected.

Background & Context

A Class I recall is triggered when there is a “reasonable probability” that use of a product could cause serious adverse health consequences or death. *Listeria* can lead to severe illness, particularly among pregnant people, the elderly, and individuals with weakened immune systems. Made Fresh Salads distributes its products directly to retail stores and distributors throughout Brooklyn, Queens, the Bronx, and the broader New York City area.

Data & Statistics

  • Number of products recalled: 61
  • Product categories: ready-to-eat deli salads, cream-cheese items, half-size aluminum pans
  • Geographic reach: Brooklyn, Queens, Bronx, and other New York City locations

Official Statements & Responses

The FDA’s notice explains that the Class I designation reflects the agency’s assessment of a “reasonable probability” of serious health outcomes from exposure to the contaminated items. Made Fresh Salads’ voluntary recall aims to remove the potentially hazardous products from the market and prevent further distribution.

Why It Matters

The heightened risk classification underscores the seriousness of *Listeria* contamination in ready-to-eat foods and signals to consumers and retailers the need for immediate removal of the affected items. Public health officials advise individuals who may have purchased the recalled salads or cream-cheese products to discard them or return them to the point of sale and to monitor for symptoms of *Listeria* infection, which can include fever, muscle aches, and gastrointestinal distress. This recall illustrates the FDA’s rapid response mechanisms for food-borne threats and highlights the importance of stringent safety controls in the ready-to-eat food sector.